Sullivan Christopher Ryan

Chief Financial Officer at AVTX

Sold, on record
$3.7M
Dollars the filings state
Form 4 sales
7
Latest Sep 16, 2026
Form 144 notices
4
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • AVTXAvalo Therapeutics, Inc.Chief Financial Officer

Sales by reason

6
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale AVTXRoutine
    Apr 30, 2026 2026

    Sold 16,915 shares at $13.16 ($223k)

    Sullivan Christopher Ryan, Chief Financial Officer

    10b5-1 planSold 97.6% of holdings ($228k position)423 shares leftFiling

  2. 2 Form 144 notice AVTXNotice
    May 6, 2026 +6 days

    Filed to sell 47,000 shares ($764k)

    Sullivan Christopher Ryan, Officer

    10b5-1 planFiling

  3. 3 Form 4 sale AVTXRoutine
    May 6, 2026 same day

    Sold 47,000 shares at $20.18 ($949k)

    Sullivan Christopher Ryan, Chief Financial Officer

    10b5-1 planSold 99.1% of holdings ($957k position)423 shares leftFiling

  4. 4 Form 144 notice AVTXNotice
    May 7, 2026 +1 day

    Filed to sell 18,606 shares ($406k)

    Sullivan Christopher Ryan, Officer

    10b5-1 plan1.1x usual sizeFiling

  5. 5 Form 4 sale AVTXRoutine
    May 7, 2026 same day

    Sold 18,606 shares at $24.12 ($449k)

    Sullivan Christopher Ryan, Chief Financial Officer

    10b5-1 planSold 97.8% of holdings ($459k position)423 shares left1.1x usual sizeFiling

  6. 6 Form 4 sale AVTXUnusual
    Aug 18, 2026 +103 days

    Sold 72,725 shares at $19.94 ($1.5M)

    Sullivan Christopher Ryan, Chief Financial Officer

    10b5-1 planSold 64.6% of holdings ($2.2M position)39,900 shares left4.1x usual sizeFiling

  7. 7 Form 4 sale AVTXRoutine
    Sep 10, 2026 +23 days

    Sold 10,185 shares at $17.62 ($179k)

    Sullivan Christopher Ryan, Chief Financial Officer

    10b5-1 planSold 20.3% of holdings ($882k position)39,900 shares left0.5x usual sizeFiling

  8. 8 Form 4 sale AVTXRoutine
    Sep 16, 2026 +6 days

    Sold 12,394 shares at $16.33 ($202k)

    Sullivan Christopher Ryan, Chief Financial Officer

    10b5-1 planSold 23.7% of holdings ($854k position)39,900 shares left0.7x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (11)

Form 144 notices and Form 4 sales by Sullivan Christopher Ryan
Source
Sep 16, 2026Sep 18, 2026AVTXChief Financial OfficerForm 4 sale12,394$202k23.7%RoutineSEC
Sep 10, 2026Sep 11, 2026AVTXChief Financial OfficerForm 4 sale10,185$179k20.3%RoutineSEC
Aug 18, 2026Aug 19, 2026AVTXChief Financial OfficerForm 4 sale72,725$1.5M64.6%UnusualSEC
May 7, 2026May 11, 2026AVTXChief Financial OfficerForm 4 sale18,606$449k97.8%RoutineSEC
May 7, 2026May 7, 2026AVTXOfficerForm 144 notice18,606$406kNoticeSEC
May 6, 2026May 7, 2026AVTXChief Financial OfficerForm 4 sale47,000$949k99.1%RoutineSEC
May 6, 2026May 6, 2026AVTXOfficerForm 144 notice47,000$764kNoticeSEC
Apr 30, 2026May 1, 2026AVTXChief Financial OfficerForm 4 sale16,915$223k97.6%RoutineSEC
Apr 29, 2026Apr 29, 2026AVTXOfficerForm 144 notice16,915$218kNoticeSEC
Apr 2, 2026Apr 3, 2026AVTXChief Financial OfficerForm 4 sale15,959$271k47.9%RoutineSEC
Apr 1, 2026Apr 1, 2026AVTXOfficerForm 144 notice15,959$238kNoticeSEC